UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061019
Receipt number R000069827
Scientific Title Long-Term Effects of an Anti-Stigma Educational Intervention During Psychiatric Clinical Clerkship on Medical Students' Stigma: A Single-Center Cluster-Randomized Longitudinal Study
Date of disclosure of the study information 2026/03/23
Last modified on 2026/03/23 15:13:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the effects of anti-stigma education during psychiatric clinical clerkship on medical students

Acronym

A study of anti-stigma education during psychiatric clinical clerkship in medical students

Scientific Title

Long-Term Effects of an Anti-Stigma Educational Intervention During Psychiatric Clinical Clerkship on Medical Students' Stigma: A Single-Center Cluster-Randomized Longitudinal Study

Scientific Title:Acronym

Long-term effects of an anti-stigma educational intervention during psychiatric clinical clerkship on stigma among medical students

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to examine whether an additional anti-stigma educational intervention during psychiatric clinical clerkship affects stigma toward mental illness among fourth- and fifth-year medical students at Kitasato University School of Medicine, and whether these effects are sustained from baseline (T0) to the end of the clerkship (T1) and 6 months after completion of the clerkship (T2). Secondary objectives are to evaluate the effects of the intervention on knowledge about mental illness, stigmatizing attitudes, behavioral intentions, empathy, and help-seeking, as well as the durability of these changes. In addition, the study will explore associations with background factors and qualitatively supplement the findings using free-text responses regarding subjective experiences of the educational content and the reasons for attitudinal changes.

Basic objectives2

Others

Basic objectives -Others

Evaluation of the effectiveness of an educational intervention

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Change in the Japanese version of the Mental Illness: Clinicians' Attitudes Scale version 4 (MICA-4) score from baseline (T0, start of the clerkship) to 6 months after completion of the clerkship (T2)

Key secondary outcomes

1) Change in the Japanese version of the Mental Illness: Clinicians' Attitudes Scale version 4 (MICA-4) score from baseline (T0, start of the clerkship) to the end of the clerkship (T1)
2) Change in the Mental Illness and Disorder Understanding Scale (MIDUS), Jefferson Scale of Empathy Japanese version (JSE-J), Attitudes Toward Seeking Professional Psychological Help Scale-Short Form (ATSPPH-SF), and Reported and Intended Behaviour Scale Japanese version future domain (RIBS-J future) scores from baseline (T0) to 6 months after completion of the clerkship (T2)
3) Change in MIDUS, JSE-J, ATSPPH-SF, and RIBS-J future scores from baseline (T0) to the end of the clerkship (T1)
4) Associations of age, sex, intention to specialize in psychiatry, prior contact with people with mental illness, and previous anti-stigma education with RIBS-J future, MIDUS, MICA-4, JSE-J, and ATSPPH-SF scores at T0, T1, and T2
5) Themes extracted from free-text responses at the end of the clerkship (T1), including memorable experiences and educational content, changes in perceptions and attitudes, and intended future clinical practice
6) Themes extracted from free-text responses 6 months after completion of the clerkship (T2), including remembered educational content, subsequent changes in perceptions and attitudes, and changes in responses in later clinical or daily-life settings


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Intervention group: In addition to usual psychiatric clinical clerkship, participants receive an additional anti-stigma educational intervention on the final day of the clerkship. Usual psychiatric clinical clerkship includes daily interviews and examinations of assigned inpatients, a basic lecture on stigma toward mental illness and small-group discussion using a vignette on the first day of the clerkship (30 minutes), and participation in or observation of psychoeducation/group sessions (90 minutes each, twice). The additional anti-stigma educational intervention is delivered on the final day of the clerkship before the T1 assessment and lasts approximately 30 minutes. It consists of viewing a video in which a person with lived experience of mental illness talks about stigma and recovery (approximately 15 minutes) and a structured reflection exercise on stigma-related experiences during the clerkship, including individual worksheet completion and group sharing (approximately 15 minutes).

Interventions/Control_2

Control group: Participants receive usual psychiatric clinical clerkship alone. Usual psychiatric clinical clerkship includes daily interviews and examinations of assigned inpatients, a basic lecture on stigma toward mental illness and small-group discussion using a vignette on the first day of the clerkship (30 minutes), and participation in or observation of psychoeducation/group sessions (90 minutes each, twice). No additional anti-stigma educational intervention is provided during the study period. For educational fairness, after completion of the 6-month follow-up assessment (T2), participants are provided with the same video material link and reflection worksheet used in the intervention group.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Fourth- or fifth-year medical students at Kitasato University School of Medicine who participate in psychiatric clinical clerkship between March 23, 2026 and March 3, 2028, and who receive an explanation of the study objectives and procedures and provide written informed consent.

Key exclusion criteria

1) Students who have previously completed psychiatric clinical clerkship at Kitasato University School of Medicine.
2) Students with no response to the self-administered questionnaire at baseline (T0).
3) Students who are absent from or discontinue the clerkship for 1 week or longer during the clerkship period.
4) Students who withdraw consent to participate in the study.

Target sample size

240


Research contact person

Name of lead principal investigator

1st name Ken
Middle name
Last name Inada

Organization

Kitasato University School of Medicine

Division name

Department of Psychiatry

Zip code

252-0374

Address

1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan

TEL

042-778-8111

Email

inadaken@kitasato-u.ac.jp


Public contact

Name of contact person

1st name Ken
Middle name
Last name Inada

Organization

Kitasato University School of Medicine

Division name

Department of Psychiatry

Zip code

252-0374

Address

1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan

TEL

042-778-8111

Homepage URL


Email

inadaken@kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato University

Institute

Department

Personal name

Ken Inada


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Kitasato University School of Medicine and Hospital Research Ethics Committee

Address

1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan

Tel

042-778-8273

Email

rinri@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学医学部精神科学および北里大学病院


Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 03 Month 18 Day

Date of IRB

2026 Year 03 Month 18 Day

Anticipated trial start date

2026 Year 03 Month 23 Day

Last follow-up date

2028 Year 09 Month 03 Day

Date of closure to data entry

2028 Year 12 Month 31 Day

Date trial data considered complete

2029 Year 03 Month 31 Day

Date analysis concluded

2031 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2026 Year 03 Month 23 Day

Last modified on

2026 Year 03 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069827